Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs
- PMID: 32115843
- DOI: 10.1111/dom.14016
Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs
Comment on
-
The importance of the initial period of basal insulin titration in people with diabetes.Diabetes Obes Metab. 2020 May;22(5):722-733. doi: 10.1111/dom.13946. Epub 2020 Jan 19. Diabetes Obes Metab. 2020. PMID: 31865632 Free PMC article. Review.
References
REFERENCES
-
- Khunti K, Giorginia F, Berard L, Mauricio, Harris SB. The importance of the initial period of basal inulin titration in people with diabetes. Diabetes Obes Metab. 2020;22:722-733.
-
- Calvert MJ, McManis RJ, Freemantle N. Management of type 2 diabetes with multiple oral hyperglycaemic agents or insulin in primary care retrospective cohort study. Br J Gen Pract. 2007;57:455-460.
-
- Rubino A, McQuay LJ, Gough SC, Kvasz V, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med. 2007;24:1412-1418.
-
- Nichols GA, Koo YH, Shah SN. Delay of insulin addition to oral comabination therapy despite inadequate glycemic control. J Gen Intern Med. 2007;22:453-458.
-
- Khunti K, Wolden MI, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36:3411-3417.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
